Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 20, 2026
May 20, 2026
cf110f90-93c7-45c0-8577-4e7a8dc9aedb
Related Documents
Pulmonary Tuberculosis: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs: Guidance for Industry
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
Certain Postapproval Requirements and Resources for ANDAs
Guidance DocumentJune 4, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.